Absci (ABSI) Operating Leases (2020 - 2026)
Absci (ABSI) posted Operating Leases of $2.1 million for Q1 2026, down 18.25% sequentially from $2.6 million in Q4 2025, and down 46.42% YoY from $4.0 million in Q1 2025.
Absci (ABSI) Operating Leases (2020 - 2026) Analysis & Trends
Absci has reported Operating Leases for 7 years, with the latest figure at $2.1 million in Q1 2026.
- Quarterly Operating Leases fell 46.42% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 46.42% YoY) and the FY2025 annual result came in at $2.6 million, down 40.75% from the prior year.
- Operating Leases fell to $2.1 million in Q1 2026 per ABSI's latest filing, from $2.6 million in the prior quarter.
- Over five years, Operating Leases peaked at $8.6 million in Q1 2022 and troughed at $2.1 million in Q1 2026.
- A 5-year average of $5.4 million and a median of $5.3 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2026: Operating Leases decreased 16.17% in 2022, then tumbled 46.42% in 2026.
- Over 5 years, Operating Leases stood at $7.3 million in 2022, then retreated by 22.88% to $5.6 million in 2023, then dropped by 21.51% to $4.4 million in 2024, then tumbled by 40.75% to $2.6 million in 2025, then decreased by 18.25% to $2.1 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $2.1 million, $2.6 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Mn |
| Mar 31, 2026 | 2.15 Mn |
| Dec 31, 2025 | 2.62 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 4.85 Mn |
| Jun 30, 2024 | 5.26 Mn |
| Mar 31, 2024 | 5.30 Mn |
| Dec 31, 2023 | 5.64 Mn |
| Sep 30, 2023 | 6.00 Mn |
| Jun 30, 2023 | 6.42 Mn |
| Mar 31, 2023 | 6.88 Mn |
| Dec 31, 2022 | 7.32 Mn |
| Sep 30, 2022 | 7.85 Mn |
| Jun 30, 2022 | 8.18 Mn |
| Mar 31, 2022 | 8.57 Mn |
| Dec 31, 2021 | 8.97 Mn |
| Sep 30, 2021 | 9.36 Mn |